Form 4: BioLife Solutions CMO Sells Shares to Cover Tax Obligations

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 348 shares of common stock for $22.46 per share to satisfy tax withholding obligations related to restricted stock vesting.

Summary

• Todd Berard, Chief Marketing Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction involved 348 shares sold at a price of $22.46 per share.
• The sale was executed on May 28, 2025.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• This transaction was conducted under a Rule 10b5-1(c) trading plan, which was adopted on February 24, 2022.
• Following this transaction, Mr. Berard beneficially owns 135,284 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine insider sale for tax purposes, pre-arranged under a 10b5-1 plan, and does not indicate a change in management's outlook or company fundamentals. Therefore, it is neutral.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Industry Context

This filing is a routine insider transaction report specific to BioLife Solutions and its Chief Marketing Officer, Todd Berard. It does not provide information relevant to broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, small-scale transaction for tax purposes, not indicative of a change in management confidence or company performance.

Key Dates

Recommendation

Keywords

BioLife Solutions, BLFS, Form 4, insider trading, stock sale, Todd Berard, Chief Marketing Officer, tax withholding, 10b5-1 plan